Biocryst Pharmaceuticals buy Needham & Company LLC

Summary

This prediction ended on 21.04.24 with a price of €4.10. The BUY prediction by Needham___Company_LL for Biocryst Pharmaceuticals performed very badly with a performance of -38.50%. Needham___Company_LL has a follow-up prediction for Biocryst Pharmaceuticals where he still thinks Biocryst Pharmaceuticals is a Buy. Needham___Company_LL has 50% into this prediction

Performance without dividends (%)

Name	1w	1m	1y
Biocryst Pharmaceuticals	-0.930%	-0.930%	4.140%
iShares Core DAX®	-1,10 %	-6,08 %	3,20 %
iShares Nasdaq 100	0,33 %	2,33 %	20,24 %
iShares Nikkei 225®	-1,08 %	-7,99 %	27,55 %
iShares S&P 500	-0,06 %	0,88 %	14,89 %